SPDR S&P Pharmaceuticals ETF (XPH)
XPH is a passive ETF by State Street tracking the investment results of the S&P Pharmaceuticals Select Industry Index. XPH launched on Jun 19, 2006 and has a 0.35% expense ratio.
ETF Info
| ISIN | US78464A7220 |
|---|---|
| CUSIP | 78464A722 |
| Issuer | State Street |
| Inception Date | Jun 19, 2006 |
| Region | North America (U.S.) |
| Category | Health & Biotech Equities |
| Index Tracked | S&P Pharmaceuticals Select Industry Index |
| Asset Class | Equity |
Asset Class Size | Multi-Cap |
Asset Class Style | Blend |
Expense Ratio
XPH has a high expense ratio of 0.35%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: XPH vs. PPH, XPH vs. XLV, XPH vs. IHE, XPH vs. ALC, XPH vs. IBB, XPH vs. FXAIX, XPH vs. NVS, XPH vs. VHT, XPH vs. BMY, XPH vs. PJP
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in SPDR S&P Pharmaceuticals ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
SPDR S&P Pharmaceuticals ETF had a return of -2.14% year-to-date (YTD) and -2.07% in the last 12 months. Over the past 10 years, SPDR S&P Pharmaceuticals ETF had an annualized return of 0.35%, while the S&P 500 had an annualized return of 10.67%, indicating that SPDR S&P Pharmaceuticals ETF did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -2.14% | 9.49% |
| 1 month | -1.64% | 1.20% |
| 6 months | 16.02% | 18.29% |
| 1 year | -2.07% | 26.44% |
| 5 years (annualized) | 1.09% | 12.64% |
| 10 years (annualized) | 0.35% | 10.67% |
Monthly Returns
The table below presents the monthly returns of XPH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0.91% | 5.76% | -2.51% | -7.74% | -2.14% | ||||||||
| 2023 | 6.32% | -5.17% | -0.40% | 2.58% | -6.23% | 4.21% | 6.66% | -0.02% | -8.80% | -9.86% | 3.27% | 12.98% | 2.97% |
| 2022 | -5.59% | -0.62% | 4.97% | -8.77% | 1.74% | 0.37% | 2.07% | -3.08% | -3.04% | 5.38% | 1.42% | -4.14% | -9.84% |
| 2021 | -0.33% | 2.83% | -5.51% | -2.30% | 2.66% | 2.68% | -2.76% | -3.67% | -1.98% | 1.10% | -4.52% | 1.22% | -10.54% |
| 2020 | -0.57% | -9.23% | -12.30% | 16.36% | 2.93% | -0.35% | -0.72% | 3.59% | -1.52% | 1.45% | 8.48% | 8.91% | 14.68% |
| 2019 | 9.58% | 6.90% | -2.92% | -4.23% | -7.71% | 8.57% | -4.67% | -6.61% | 0.59% | 8.65% | 5.84% | 11.76% | 25.62% |
| 2018 | 2.60% | -6.86% | 0.77% | -3.82% | 4.54% | 2.30% | 8.00% | 7.56% | -2.69% | -10.87% | 0.85% | -15.85% | -15.32% |
| 2017 | -0.72% | 7.81% | 0.04% | 2.94% | -3.14% | 3.38% | 0.33% | -0.60% | -0.67% | -4.68% | 6.02% | 1.42% | 12.05% |
| 2016 | -16.03% | -5.33% | -1.06% | 5.07% | 2.96% | -3.83% | 9.99% | -2.35% | -1.43% | -10.05% | -1.28% | -0.15% | -23.20% |
| 2015 | 3.17% | 11.04% | 0.03% | -5.06% | 5.99% | 0.46% | 5.01% | -11.58% | -18.85% | 4.07% | 10.49% | 1.28% | 1.65% |
| 2014 | 4.01% | 8.42% | -5.51% | 2.36% | 3.34% | 4.97% | -8.37% | 9.25% | 2.25% | 5.07% | 3.32% | -1.49% | 29.52% |
| 2013 | 7.89% | 1.71% | 3.09% | 4.61% | 4.75% | 2.11% | 8.11% | -1.31% | 2.50% | 1.74% | 12.45% | 1.56% | 60.84% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of XPH is 9, indicating that it is in the bottom 9% of ETFs on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
XPH (SPDR S&P Pharmaceuticals ETF)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
SPDR S&P Pharmaceuticals ETF granted a 1.46% dividend yield in the last twelve months. The annual payout for that period amounted to $0.59 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.59 | $0.53 | $0.67 | $0.44 | $0.24 | $0.29 | $0.24 | $0.29 | $0.25 | $3.66 | $3.00 | $0.91 |
Dividend yield | 1.46% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% | 5.55% | 2.06% |
Monthly Dividends
The table displays the monthly dividend distributions for SPDR S&P Pharmaceuticals ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | |||||||
| 2023 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.17 | $0.53 |
| 2022 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.19 | $0.67 |
| 2021 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.19 | $0.44 |
| 2020 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.05 | $0.24 |
| 2019 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.08 | $0.00 | $0.00 | $0.07 | $0.29 |
| 2018 | $0.00 | $0.00 | $0.02 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.11 | $0.24 |
| 2017 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.11 | $0.29 |
| 2016 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.09 | $0.25 |
| 2015 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.09 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $3.39 | $3.66 |
| 2014 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.07 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $2.74 | $3.00 |
| 2013 | $0.03 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.71 | $0.91 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the SPDR S&P Pharmaceuticals ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the SPDR S&P Pharmaceuticals ETF was 48.03%, occurring on Mar 23, 2020. The portfolio has not yet recovered.
The current SPDR S&P Pharmaceuticals ETF drawdown is 30.06%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -48.03% | Jul 23, 2015 | 1175 | Mar 23, 2020 | — | — | — |
| -35.26% | May 10, 2007 | 450 | Mar 5, 2009 | 155 | Oct 14, 2009 | 605 |
| -17.59% | Jul 8, 2011 | 22 | Aug 8, 2011 | 106 | Jan 9, 2012 | 128 |
| -14.51% | Mar 6, 2014 | 28 | Apr 14, 2014 | 47 | Jun 20, 2014 | 75 |
| -13.17% | Sep 19, 2012 | 40 | Nov 15, 2012 | 63 | Feb 19, 2013 | 103 |
Volatility
Volatility Chart
The current SPDR S&P Pharmaceuticals ETF volatility is 5.02%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.